Navigation Links
Surviving Healthcare Reform: How Biopharma Companies Can Come Out on Top
Date:11/6/2009

STAMFORD, Conn. and WESTON, Mass., Nov. 6 /PRNewswire/ -- Those biopharmaceutical companies that are able to incorporate innovative and flexible elements into their business models will be best positioned to survive healthcare reform and maintain attractive long-term returns, according to a white paper published today by Cowen Healthcare Royalty Partners, a global healthcare private equity firm, and Health Advances, a leading healthcare strategy firm.

The paper, "Maintaining Attractive Biopharma Returns in the Face of Healthcare Reform", examines key issues at the center of the debate including access to care, controlling costs, drug pricing and value-based healthcare. In addition to discussing the increased pressures biopharma companies face, including the restrictive use of branded drugs for large patient populations and follow-on biologics, the paper outlines new solutions companies can implement to achieve the same levels of return for its investments as it has in the past.

Some of the paper's key findings include:

  • Biopharma companies need to adapt their business models to maintain attractive ROIs such as exploring pay-for-performance relationships with stakeholders, cost-effective care solutions that align incentives, and investing in follow-on biologics and/or generics
  • Investing in pharmacoeconomic competencies and integrating these into clinical development will mitigate reimbursement risk
  • Investing in personalized healthcare and specifically biomarkers will be rewarded
  • Highly differentiated products addressing niche markets will be the least vulnerable even if stringent regulation is passed

Gregory B. Brown, M.D., Co-Founder and Managing Director of Cowen Royalty, commented, "Healthcare reform is a serious issue for biopharma companies who are already feeling pressure from patent expirations, fewer drug approvals and growing development costs. We partnered with Health Advances to bring a new and unique perspective on the healthcare debate especially as it relates to biopharma companies -- the developers of many of our future medicines."

To download a copy of the white paper visit http://www.cowenroyalty.com/content/news/publications-presentations.htm.

About Cowen Healthcare Royalty Partners:

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purchase of royalty interests. The investment team has over 100 years of healthcare related experience including principal investing, structured finance, healthcare industry senior management, Wall Street research and consulting, scientific and clinical experience. For more information, visit www.cowenroyalty.com.

About Health Advances:

Founded in 1992, Health Advances is a leading healthcare strategy firm advising clients in the biopharma, device and diagnostic sectors. Industry executives and investors rely on Health Advances to advise them on their most challenging commercial decisions. For more information regarding our consulting services, visit www.healthadvances.com.

Media Contact:

    Kellie Walsh
    914-315-6072
    kwalsh@kwmcommunications.com

SOURCE Cowen Healthcare Royalty Partners


'/>"/>
SOURCE Cowen Healthcare Royalty Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chemobrain -- the flip side of surviving cancer
2. More Women Surviving After Early Breast Cancer
3. Early Menstruation Lowers Odds of Surviving Ovarian Cancer
4. More Extreme Preemies Surviving
5. Spike TV Goes Into Production of Special Episode of Original Series Surviving Disaster Focused on the Swine Flu and Other Pandemics
6. Surviving lung cancer
7. National Coalition for Cancer Survivorship, UCLA, WellPoint, and Genentech Launch Initiative to Provide Coordinated Follow-Up Care for People Surviving Cancer
8. White patients benefit more than blacks in surviving surgical complications at teaching hospitals
9. White Patients Benefit More Than Blacks in Surviving Surgical Complications at Teaching Hospitals
10. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
11. Surviving the Holidays After a Loved Ones Death: Economic Woes Add to Holiday Pressure for People Who Grieve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who want to experience the ... can now have them placed by Dr. Manju Kejriwal, with or without a referral. ... to increase the accuracy of each dental implant placement. The i-CAT CBCT system captures ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall ... their patients about the key role this treatment plays in protecting oral health, along ... To better serve those who need a root canal in White Plains, NY or ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... site attention and engagement over the household brands of Top-20 pharma by optimizing ... discuss how partnering with the right outsourcing payments provider can provide the technology, ...
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... 3.0 was transitioned to the OSEHRA popHealth Community in 2014. It ... Work Group and the Developer Open Source Project Group. OSEHRA Organizational Member Zato ...
(Date:3/27/2017)... ... ... A study by the founder of the Buckingham Center for Facial ... recently published in the American Journal of Cosmetic Surgery. “The Effects of an Antistick ... on the use of Electro Lube during the facelift procedure. The journal, a publication ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... -- Summary This report provides all ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/27/2017)... Summary This report provides all the information ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
Breaking Medicine Technology: